Company Monitoring Page for Amgen

job ratings (see below graph) for Amgen

latest headlines for company on cafepharma

Why Amgen Is the Best S&P 500 Company
TheStreet.com
Tue, 03/22/16 - 09:50 am
Tags:
Amgen
Amgen signs 'flexible manufacturing agreement' with CMO Patheon
BioPharma Dive
Thu, 03/17/16 - 02:41 pm
Tags:
Amgen, CMOs, Patheon, drug manufacturing, contract drug manufacturing
Regeneron, Sanofi Strongly Disagree to Jury’s Verdict in Amgen Patent Trial
Bidness, ETC
Wed, 03/16/16 - 07:22 pm
Tags:
Sanofi, Regeneron, Amgen, patents, PCSK9, Repatha, Praluent
Amgen Is Open to Bigger Deals While Staying Disciplined
Bloomberg
Tue, 03/8/16 - 10:28 am
Tags:
Amgen, M&A
Amgen Inc to Face Off Pfizer & Novartis to Save Key Drugs
Bidness, ETC
Fri, 03/4/16 - 02:09 pm
Tags:
Amgen, Pfizer, Novartis, Enbrel, Epogen
Amgen going after Novartis for Enbrel patent infringement
BioPharma Dive
Thu, 03/3/16 - 10:45 am
Tags:
Amgen, Novartis, Enbrel, patents, biosimilars
Amgen's bone-building osteo drug dazzles in phase 3, but could face hefty competition
BioPharma Dive
Wed, 02/24/16 - 04:48 pm
Tags:
romosozumab, Amgen, osteoporosis, clinical trials, Eli Lilly, Forteo, Radius Health, abaloparatide
Amgen, UCB say osteoporosis drug meets main goal in late-stage trial
Yahoo/Reuters
Mon, 02/22/16 - 09:40 am
Tags:
Amgen, UCB Pharma, osteoporosis, clinical trials, romosozumab
Better Buy: Gilead Sciences Inc. vs. Amgen Inc.
Motley Fool
Sun, 02/21/16 - 11:37 am
Tags:
Gilead Sciences, Amgen
Amgen launches Kyprolis in the UK for multiple myeloma
BioPharma Dive
Thu, 02/18/16 - 05:48 pm
Tags:
Amgen, Kyprolis, UK, Multiple Myeloma
Sandoz Petitions High Court to Review the Federal Circuit’s Decision on the BPCIA’s 180-Day Notice of Commercial Marketing Provision
FDA Law Blog
Wed, 02/17/16 - 11:33 am
Tags:
Sandoz, FDA, BPCIA, Amgen, Zarxio, Neupogen
Amgen Ahead of Regeneron; Controlling 60% of PCSK-9 Market
Bidness, ETC
Wed, 02/17/16 - 10:46 am
Tags:
Amgen, Regeneron, Sanofi, PCSK9 inhibitors, Repatha, Praluent
Amgen blood cell disorder drug meets primary goal in phase 3 trial
Yahoo/Reuters
Tue, 02/16/16 - 10:01 am
Tags:
Amgen, Aranesp, MDS, clinical trials
Express Scripts sees slow 2016 sales for new cholesterol drugs
Yahoo/Reuters
Fri, 02/12/16 - 04:15 pm
Tags:
Express Scripts, PCSK9 inhibitors, Amgen, Regeneron, Sanofi, Repatha, Praluent
Big Pharma's new PCSK9, heart failure meds stuck in the slow lane. What gives?
Fierce Pharma Marketing
Wed, 02/10/16 - 03:20 pm
Tags:
PCSK9 inhibitors, heart failure, Praluent, Repatha, Novartis, Amgen, Sanofi, Regeneron
Amgen Is Now Strides Ahead of Regeneron in the PCSK9 Race
Bidness, ETC
Tue, 02/9/16 - 04:23 pm
Tags:
Amgen, Regeneron, PCSK9 inhibitors, Praluent, Repatha
Is the Anti-TNF Lead of AbbVie, Amgen, JNJ Nearing an End?
Bidness, ETC
Mon, 02/8/16 - 11:01 am
Tags:
AbbVie, Amgen, JNJ, anti-TNF, Remicade
Pharmaceuticals Turn To Politics To Protect Prices
Yahoo/Benzinga
Mon, 02/8/16 - 10:20 am
Tags:
drug pricing, Amgen, Pfizer, 2016 Presidential election
How Amgen may Impact Regeneron Q4 Earnings
Bidness, ETC
Thu, 02/4/16 - 06:33 pm
Tags:
Amgen, Regeneron, earnings
Genentech snags a PhII-ready IL-33 asthma/COPD drug from Amgen
Fierce Biotech
Fri, 01/29/16 - 08:27 pm
Tags:
Genentech, asthma, COPD, IL-33, Amgen

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.